4 days ago · Journavx (suzetrigine) is a new non-opioid pain-relieving tablet used to treat short-term (acute) moderate to severe pain. Journavx is a sodium channel blocker that relieves pain by blocking pain-sensing nerves around the body from transmitting pain …

Ask your doctor about JOURNAVX, an oral medication that reduces pain signals before they reach the brain. a Acute pain is a type of pain that starts suddenly and lasts less than 3 months. It's often caused by an injury or surgery.

1 day ago · Suzetrigine is a white to off-white solid and is practically insoluble in water. JOURNAVX is available as a blue, film-coated tablet for oral administration containing 50 mg of suzetrigine and the following inactive ingredients: croscarmellose sodium, hypromellose acetate succinate, magnesium stearate, and microcrystalline cellulose.

Jan 30, 2025 · Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.

Jan 30, 2025 · JOURNAVX is a prescription medicine used to treat adults with moderate-to-severe short term (acute) pain. It is not known if JOURNAVX is safe and effective in children. IMPORTANT SAFETY INFORMATION. Patients should not take JOURNAVX if they take certain medicines that are strong inhibitors of an enzyme called CYP3A. Patients should ask their ...

6 days ago · Journavx has a list price of $15.50 per pill, which is significantly more expensive than comparable opioids. However, it’s unclear to what extent insurers could cover the medicine, and patient ...

Journavx is an effective, well-tolerated medicine without evidence of addictive potential indicated for use across all types of moderate-to-severe acute pain.

Jan 30, 2025 · A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

Jan 30, 2025 · Researchers say they expect it to be the first of a new generation of more powerful nonaddictive drugs to relieve pain. To test the drug, Vertex, which is based in Boston, conducted two large...

6 days ago · For the first time in 25 years, the U.S. Food and Drug Administration has approved a new type of painkiller. Suzetrigine, sold as Journavx, is administered twice daily in 50-milligram oral tablets ...